| Literature DB >> 25066121 |
Paolo E Porporato1, Valéry L Payen1, Jhudit Pérez-Escuredo1, Christophe J De Saedeleer1, Pierre Danhier2, Tamara Copetti1, Suveera Dhup1, Morgane Tardy1, Thibaut Vazeille1, Caroline Bouzin1, Olivier Feron1, Carine Michiels3, Bernard Gallez2, Pierre Sonveaux4.
Abstract
Metastatic progression of cancer is associated with poor outcome, and here we examine metabolic changes underlying this process. Although aerobic glycolysis is known to promote metastasis, we have now identified a different switch primarily affecting mitochondria. The switch involves overload of the electron transport chain (ETC) with preserved mitochondrial functions but increased mitochondrial superoxide production. It provides a metastatic advantage phenocopied by partial ETC inhibition, another situation associated with enhanced superoxide production. Both cases involved protein tyrosine kinases Src and Pyk2 as downstream effectors. Thus, two different events, ETC overload and partial ETC inhibition, promote superoxide-dependent tumor cell migration, invasion, clonogenicity, and metastasis. Consequently, specific scavenging of mitochondrial superoxide with mitoTEMPO blocked tumor cell migration and prevented spontaneous tumor metastasis in murine and human tumor models.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25066121 DOI: 10.1016/j.celrep.2014.06.043
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423